高级检索
    乔贵宾, 张涛. 吉非替尼在伴有EGFR敏感突变Ⅱ~ⅢA期非小细胞肺癌术后辅助治疗的应用[J]. 循证医学, 2018, 18(4): 230-232. DOI: 10.12019/j.issn.1671-5144.2018.04.010
    引用本文: 乔贵宾, 张涛. 吉非替尼在伴有EGFR敏感突变Ⅱ~ⅢA期非小细胞肺癌术后辅助治疗的应用[J]. 循证医学, 2018, 18(4): 230-232. DOI: 10.12019/j.issn.1671-5144.2018.04.010
    shu
    Reviewer: QIAO Gui-bin, Literature Co-worker: ZHANG Tao. The Application of Geftinib as Adjuvant Therapy for Stage Ⅱ~ⅢA EGFR-Mutant Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(4): 230-232. DOI: 10.12019/j.issn.1671-5144.2018.04.010
    Citation: Reviewer: QIAO Gui-bin, Literature Co-worker: ZHANG Tao. The Application of Geftinib as Adjuvant Therapy for Stage Ⅱ~ⅢA EGFR-Mutant Non-Small Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2018, 18(4): 230-232. DOI: 10.12019/j.issn.1671-5144.2018.04.010
    shu

    吉非替尼在伴有EGFR敏感突变Ⅱ~ⅢA期非小细胞肺癌术后辅助治疗的应用

    The Application of Geftinib as Adjuvant Therapy for Stage Ⅱ~ⅢA EGFR-Mutant Non-Small Cell Lung Cancer

      摘要
      • HTML全文
      • 参考文献(7)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回